A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel Diseases
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel Diseases
Authors
Keywords
Cost-effectiveness analysis, Ulcerative colitis, Surgical and invasive medical procedures, Markov models, Systematic reviews, Inflammatory bowel disease, Indirect costs, Cytokines
Journal
PLoS One
Volume 10, Issue 12, Pages e0145087
Publisher
Public Library of Science (PLoS)
Online
2015-12-17
DOI
10.1371/journal.pone.0145087
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biologic agents for IBD: practical insights
- (2015) Silvio Danese et al. Nature Reviews Gastroenterology & Hepatology
- Real-life Treatment Paradigms Show Infliximab Is Cost-effective for Management of Ulcerative Colitis
- (2014) Victoria Ung et al. Clinical Gastroenterology and Hepatology
- Tumor Necrosis Factor Alpha Blocking Agents as Treatment for Ulcerative Colitis Intolerant or Refractory to Conventional Medical Therapy: A Meta-Analysis
- (2014) Ruxi Lv et al. PLoS One
- Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies
- (2013) Alexandra D. Frolkis et al. GASTROENTEROLOGY
- A Systematic Review of Economic Studies on Biological Agents Used to Treat Crohn’s Disease
- (2013) Derek H. Tang et al. INFLAMMATORY BOWEL DISEASES
- The burden of inflammatory bowel disease in Europe
- (2013) Johan Burisch et al. Journal of Crohns & Colitis
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
- (2013) Don Husereau et al. VALUE IN HEALTH
- Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study
- (2012) Mirthe Emilie van der Valk et al. GUT
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
- (2012) Axel Dignass et al. Journal of Crohns & Colitis
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
- (2012) Axel Dignass et al. Journal of Crohns & Colitis
- Economic impact of combination therapy with infliximab plus azathioprine for drug-refractory Crohn's disease: A cost-effectiveness analysis
- (2012) Shota Saito et al. Journal of Crohns & Colitis
- Cost-Utility Analysis of Biologic Treatments for Moderate-to-Severe Crohn's Disease
- (2012) Derek H. Tang et al. PHARMACOTHERAPY
- Strategies for the Prevention of Postoperative Recurrence in Crohn's Disease: Results of a Decision Analysis
- (2011) Ashwin N Ananthakrishnan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Certolizumab Pegol Compared to Natalizumab in Patients with Moderate to Severe Crohn’s Disease: Results of a Decision Analysis
- (2011) Ashwin N. Ananthakrishnan et al. DIGESTIVE DISEASES AND SCIENCES
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohnʼs disease
- (2011) Glen A. Doherty et al. INFLAMMATORY BOWEL DISEASES
- Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease
- (2011) Gord Blackhouse et al. Journal of Crohns & Colitis
- Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn’s disease - modelling outcomes in active luminal and fistulizing disease in adults
- (2010) J. LINDSAY et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
- (2010) Gert Van Assche et al. Journal of Crohns & Colitis
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
- (2010) A. Dignass et al. Journal of Crohns & Colitis
- Cost-effectiveness of biological therapy for Crohn’s disease: Markov cohort analyses incorporating United Kingdom patient-level cost data
- (2009) K. BODGER et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Management of Crohn's Disease in Adults
- (2009) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Cost-effectiveness of adalimumab for the maintenance of remission in patients with Crohnʼs disease
- (2009) Edward V. Loftus et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?
- (2009) Takeru Shiroiwa et al. HEALTH ECONOMICS
- A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis
- (2008) H. H. TSAI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Role of Economic Evidence in Canadian Oncology Reimbursement Decision-Making: To Lambda and Beyond
- (2008) Angela Rocchi et al. VALUE IN HEALTH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started